Laidlaw Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,668
Closed -$235K – 333
2023
Q2
$235K Sell
2,668
-474
-15% -$40.8K 0.05% 303
2023
Q1
$253K Buy
3,142
+525
+20% +$42.8K 0.05% 287
2022
Q4
$203K Sell
2,617
-306
-10% -$24.8K 0.04% 337
2022
Q3
$236K Sell
2,923
-324
-10% -$29.1K 0.06% 273
2022
Q2
$291K Sell
3,247
-318
-9% -$32.2K 0.06% 275
2022
Q1
$396K Sell
3,565
-491
-12% -$51.9K 0.07% 255
2021
Q4
$420K Sell
4,056
-2,926
-42% -$339K 0.07% 250
2021
Q3
$875K Sell
6,982
-309
-4% -$40K 0.22% 100
2021
Q2
$905K Buy
7,291
+2,658
+57% +$334K 0.23% 98
2021
Q1
$547K Buy
4,633
+429
+10% +$50.3K 0.19% 116
2020
Q4
$492K Buy
4,204
+1,218
+41% +$134K 0.1% 194
2020
Q3
$310K Buy
2,986
+130
+5% +$13.1K 0.14% 148
2020
Q2
$262K Buy
2,856
+620
+28% +$59.5K 0.14% 143
2020
Q1
$202K Buy
2,236
+8
+0.4% +$851 0.13% 140
2019
Q4
$253K Buy
+2,228
New +$244K 0.16% 138

Other funds holding MDT

Laidlaw Wealth Management's MDT Position: Q3 2023 in Review

Laidlaw Wealth Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,668 shares — an estimated $235K sold.

Laidlaw Wealth Management first reported a position in MDT in Q4 2019 and held it in 15 quarters. The position peaked at $905K in Q2 2021. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Laidlaw Wealth Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Laidlaw Wealth Management sold 2,668 Medtronic shares in Q3 2023, an estimated $235K.
  • Laidlaw Wealth Management first reported a position in Medtronic in Q4 2019 and held it in 15 quarters.
  • Laidlaw Wealth Management's Medtronic position peaked at $905K in Q2 2021.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Laidlaw Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.